Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
US9604945B2 · kind B2 · utility
0Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2013 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Mar 27, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.